HKEX Stock Code: 01093English|繁體|简体

Highlight - 2025Q1 Results

Revenue
RMB7,015M, -21.9%
Reported profit attributable to shareholders of the Company
RMB1,478M, -8.4%
Underlying profit attributable to shareholders of the Company
RMB1,411M, -18.2%
Basic earnings per share (based on reported profit)
RMB12.91 cents, -5.1%
Basic earnings per share (based on underlying profit)
RMB12.32 cents, -15.3%

Key Products

Finished drugs
Bulk drugs
© Copyright 2025 CSPC Pharmaceutical Group Limited. All Rights Reserved.